Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 10-2005 | 10-2004 | 10-2003 | 10-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 98,800 | 31,600 | -39,800 | -980,200 |
| Depreciation Amortization | N/A | 66,900 | 40,900 | 53,400 | 100,800 |
| Income taxes - deferred | N/A | 2,500 | 1,900 | N/A | 498,100 |
| Accounts receivable | N/A | -28,900 | -7,000 | 1,900 | 106,000 |
| Accounts payable and accrued liabilities | N/A | 100 | 800 | -29,500 | -77,100 |
| Other Working Capital | N/A | -94,900 | 10,700 | -3,000 | 15,700 |
| Other Operating Activity | 0 | 19,200 | -71,000 | 49,000 | 396,400 |
| Operating Cash Flow | $N/A | $63,700 | $7,900 | $32,000 | $59,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -18,700 | -3,200 | -67,600 | -25,600 |
| Net Acquisitions | N/A | -140,400 | -227,300 | 1,900 | -1,900 |
| Purchase Of Investment | N/A | -957,400 | -2,073,200 | -652,200 | N/A |
| Sale Of Investment | N/A | 1,071,200 | 2,115,900 | 159,500 | 70,900 |
| Other Investing Activity | 0 | 17,200 | -4,600 | 161,400 | -177,000 |
| Investing Cash Flow | $N/A | $-28,100 | $-192,400 | $-397,000 | $-133,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -10,700 | 371,700 | -5,200 |
| Common Stock Issued | N/A | 13,600 | 3,700 | 8,200 | 9,100 |
| Other Financing Activity | 0 | 0 | 0 | -34,500 | 0 |
| Financing Cash Flow | $N/A | $13,600 | $-7,000 | $345,400 | $3,900 |
| Exchange Rate Effect | N/A | -4,500 | -200 | 800 | 200 |
| Beginning Cash Position | N/A | 63,500 | 255,500 | 276,700 | 347,500 |
| End Cash Position | N/A | 108,200 | 63,800 | 257,900 | 277,700 |
| Net Cash Flow | $N/A | $44,700 | $-191,700 | $-18,800 | $-69,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 63,700 | 7,900 | 32,000 | 59,700 |
| Capital Expenditure | N/A | -35,400 | -14,400 | -69,500 | -25,600 |
| Free Cash Flow | 0 | 28,300 | -6,500 | -37,500 | 34,100 |